15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for CELZ yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $1.25 current
Highest Target—
Average Target—
Lowest Target—
CELZ EPS & revenue forecast
EPS · NEXT QUARTER
$-0.24
Range $-0.24 – $-0.24 · 1 analysts · -70% YoY
Next period, 1 analysts expect Creative Medical Technology Holdings Inc to earn $-0.24 a share (range $-0.24 – $-0.24), versus $-0.80 a year earlier. Full-year consensus is $-1.18, growing to $-0.88 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts · -100% YoY
Revenue is expected to reach $0 (range $0 – $0), -100.0% year-over-year. Full-year consensus is $0, rising to $0 next year.
CELZ stock forecast FAQ
What is Creative Medical Technology Holdings Inc's projected EPS for next quarter?+
The consensus estimate is $-0.24 per share (range $-0.24 – $-0.24) across 1 analysts. Full-year EPS is projected at $-1.18, rising to $-0.88 the following year.
How much revenue is Creative Medical Technology Holdings Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CELZ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
